Optomed is a Finnish medical technology company and a leading manufacturer of handheld fundus cameras and screening software. Optomed combines handheld fundus cameras with software and artificial intelligence with the aim to transform the diagnostic process of blinding eye diseases, such as rapidly increasing diabetic retinopathy. Optomed has offices in Finland, the US and China and the company’s products are sold via various sales channels in over 60 countries globally. The company has an extensive portfolio of over 50 international patents protecting the technology. The products have medical approvals in all key markets, including CE (Europe) and FDA (USA), and CFDA (China).